Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 17, 2005

View Archived Issues

P-selectin inhibitor from Wyeth effective in models of vascular inflammation and atherosclerosis

Similar PK parameters reported for two oral formulations of rizatriptan in healthy subjects

Central effects of cannabinoids

NK1 receptor antagonism elicits antitumor activity

New data on the pharmacokinetics and pharmacodynamics of dabigatran

Update on the effects and safety of INS-50589

Phase II data on rhThrombin in the management of postoperative bleeding

Active second quarter at Schering-Plough

Meda to acquire Viatris

RegeneRx collaborates with Children's National Medical Center for TB4

Samaritan establishes Samaritan Europe

Teva receives follow-up approvable letter for Agilect

Acambis and VIB team up on flu vaccine development

ODAC schedules reviews for September meeting

European MRP completed for Remodulin

ChondroGene forms alliance with UCSF

FDA explains clinical hold of phase II study of arimoclomol for ALS

Orthokine shows efficacy for osteoarthritis

ChemGenex receives grants for diabetes research

Corautus Genetics signs agreements for VEGF-2 for diabetic neuropathy

AnGes and Avontec sign crosslicense agreement

Positive outcomes from phase III study of regadenoson for MPI

FDA approval for Fortical

New therapeutics for cancer disclosed in recent patent literature

Recent patents reveal novel agents for respiratory diseases

Therapeutic agents for arthritis and other musculoskeletal diseases prepared and tested

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...